Nurix Therapeutics Inc. (NRIX)

11.41

0.94 (8.98%)

At close: Apr 02, 2025, 3:59 PM

11.03

-3.34%

Pre-market: Apr 03, 2025, 06:35 AM EDT

Nurix Therapeutics Cash Flow Statement

Chart Mode

Financials in USD. Fiscal year is December - November.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020	Nov 30, 2019	Nov 30, 2018
Net Income	-193.57M	-143.95M	-180.36M	-117.19M	-43.24M	-21.7M	-9.43M
Depreciation & Amortization	-1.97M	13.65M	10.81M	6.08M	2.18M	2.35M	2.99M
Stock-Based Compensation	33.93M	33.67M	28.13M	15.8M	4.3M	510K	431K
Other Working Capital	-23.61M	18.51M	-25.11M	6.75M	35.17M	19.24M	-24.79M
Other Non-Cash Items	-10.97M	-4.87M	636K	1.83M	273K	-109K	-6K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	-354K
Change in Working Capital	n/a	20.12M	-19.02M	9.11M	36.41M	19.55M	-25.31M
Operating Cash Flow	-172.58M	-81.36M	-159.81M	-84.36M	-80K	601K	-31.68M
Capital Expenditures	-9.27M	-8.4M	-12.24M	-5.66M	-4.55M	-1.65M	-1.59M
Acquisitions	n/a	n/a	-39.44M	102.59M	249.85M	-10.15M	6K
Purchase of Investments	-707.95M	-246.33M	-239.37M	-348.5M	-275.22M	-9.35M	-12.92M
Sales Maturities Of Investments	459.51M	323.04M	278.81M	245.91M	25.37M	19.5M	54.5M
Other Investing Acitivies	n/a	n/a	39.44M	-102.59M	-249.85M	10.15M	6K
Investing Cash Flow	-257.71M	68.3M	27.2M	-108.25M	-254.4M	8.5M	39.99M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-16K	-2K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	7.17M	3.22M	97.79M	3.73M	963K	126K	529K
Financial Cash Flow	485.67M	3.22M	117.19M	153.88M	339.02M	126K	529K
Net Cash Flow	55.37M	-9.85M	-15.42M	-38.73M	84.54M	9.22M	8.85M
Free Cash Flow	-181.86M	-89.77M	-172.05M	-90.03M	-4.63M	-1.05M	-33.27M